Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 6Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Burkitt Lymphoma 1

Interventions

Specimen Handling 149pembrolizumab 130Magnetic Resonance Spectroscopy 120Cyclophosphamide 117Biopsy 102fludarabine 89Nivolumab 58Carboplatin 53Cisplatin 48Radiotherapy 46Gemcitabine 46venetoclax 43Paclitaxel 41Cetuximab 41fludarabine phosphate 39Ipilimumab 35atezolizumab 34Fluorouracil 34Bevacizumab 33durvalumab 29Radiation 28Oxaliplatin 28Leucovorin 28Dexamethasone 28X-Rays 26Irinotecan 26Cytarabine 26Azacitidine 26Radiosurgery 24Injections 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × azathiopurine × 90 days × Clear all
NCT05157971 2026-05-28

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡